
The Toro Company (TTC) reported mixed fiscal Q3 results, with net sales declining 2% to $1.13 billion, missing estimates, and reported net earnings significantly impacted by a non-cash impairment charge. Conversely, adjusted diluted EPS rose 5% to $1.24, surpassing expectations, attributed to strong Professional segment growth. Despite this adjusted earnings beat, Toro narrowed its fiscal 2025 guidance for both adjusted EPS and net sales below prior estimates. TTC shares gained 1.9% post-announcement, with analysts subsequently raising price targets, suggesting market focus on the adjusted profitability and segment strength despite overall sales softness and a conservative forward outlook.
The Toro Company (TTC) presented a mixed fiscal third-quarter performance, characterized by a conflict between top-line pressure and bottom-line operational outperformance. Net sales declined 2% year-over-year to $1.13 billion, missing the $1.16 billion analyst consensus. Reported net earnings fell sharply to $53.5 million, though this was heavily skewed by a significant non-cash pretax impairment charge of $81 million. Excluding this charge, adjusted diluted earnings per share rose 5% to $1.24, surpassing the $1.22 estimate, a beat attributed by management to the Professional segment's 6% growth and notable 250 basis point margin expansion. This operational strength, however, is contrasted by a more cautious forward outlook. Management narrowed its fiscal 2025 guidance, with both adjusted EPS now expected at approximately $4.15 and net sales at $4.446 billion, figures that fall below prior analyst estimates. Despite the revenue miss and guidance reduction, the market reaction was positive, with shares gaining 1.9% and analysts from Baird and DA Davidson raising their price targets, suggesting investors are prioritizing the current adjusted profitability and margin strength over the softer revenue outlook.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mixed
Sentiment Score
0.10
Ticker Sentiment